Cite

HARVARD Citation

    Blank, C. et al. (2018). Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma. Nature medicine. pp. 1655-1661. [Online]. 
  
Back to record